Investigating Βpix As a Novel Upstream Regulator of the Hippo Pathway

Total Page:16

File Type:pdf, Size:1020Kb

Investigating Βpix As a Novel Upstream Regulator of the Hippo Pathway Investigating βPix as a novel upstream regulator of the Hippo pathway by Ki Myung Song A thesis submitted in conformity with the requirements for the degree of Master of Science Department of Biochemistry University of Toronto © Copyright by Ki Myung Song 2015 Investigating βPix as a novel upstream regulator of the Hippo pathway Ki Myung Song Master of Science Department of Biochemistry University of Toronto 2015 Abstract The Hippo pathway regulates cell growth and organ size and dysregulation of the pathway leads to cancer. In mammals, the core Hippo pathway consists of Mst/Lats kinases, which phosphorylate and inhibit transcriptional co-activators, Yap and Taz, by promoting cytoplasmic sequestration. Here, we identify the guanine nucleotide exchange factor (GEF), Arhgef7, or βPix, as a positive Hippo pathway regulator. Upon upstream Hippo signals emanating from cell-cell contact and actin cytoskeletal rearrangements, βPix functions to regulate Yap/Taz localization and activity in a GEF-independent manner. βPix interacts with Yap via the C-terminal KER domain and this physical interaction plays a key role in βPix-mediated Yap/Taz regulation. In normal mammary epithelial cells, Lats kinases are required for βPix function while Mst kinases are not required for Hippo signalling. In breast cancer cells, ectopic expression of βPIX is sufficient to re-couple the Hippo kinase cassette to Yap/Taz, suggesting a possible role as a tumour suppressor. ii Acknowledgments I would like to express my deepest gratitude to my supervisor, Professor Liliana Attisano, for her guidance, invaluable insights and engagement throughout the learning process of my Master’s thesis. This dissertation would not have been possible without her unprecedented supervision and constant support. I would also like to extend my appreciation to my committee members, Professor Andrew Wilde and Professor Michael Ohh. I am sincerely grateful for their helpful advice and genuine remarks during the course of my study. I want to express my warmest thanks to all members of the Attisano Lab, past and present, for offering suggestions and assistance on numerous occasions, sharing their knowledge and techniques, and encouraging me with kind words and hearts. I would also like to thank Dr. Jeff Wrana and all members of the Wrana lab for sharing their expertise and intuitions. Last but not least, I want to wholeheartedly thank my loved ones, including my parents, siblings and friends. I have stumbled and fallen many times, but I was able to get up with their love and support from both local and overseas. I love you. iii Table of Contents Abstract…………………………………………………………………………………………………….…ii Acknowledgements........................................................................................................................iii List of Tables………………………………………………...……………………………..………………vii List of Figures…..……….………………………………………………………………………………..viii Chapter 1: Introduction……………………………………………………………………..……1 1.1 Core components of the Hippo pathway……..……………………..…………………1 1.1.1 Mst1 and Mst2 kinases…………………………………………………….3 1.1.2 Lats1 and Lats2 kinases…………………………………………………...5 1.1.3 Yap and Taz……………………………………………………………….6 1.2 Upstream regulators of the Hippo pathway…………………………..……………….8 1.2.1 Apical-basal polarity…………………..………………………………….....8 1.2.2 Planar cell polarity (PCP)………………………………………………….12 1.2.3 Mechanotransduction ………………………...……………………………13 1.2.4 G-protein-coupled receptor (GPCR) signalling ...…………………………15 1.3 Biological implications of the Hippo pathway…...………….………………………15 1.4 αPix and βPix ……………………………………...…………………..…………….18 1.4.1 Structure of Pix…………………………………………………………….18 1.4.2 Function of Pix……………………………………………………………..19 1.4.3 βPix-Git complex…………………………………………………………..21 iv 1.5 Thesis overview………………….…………………………………………………..22 Chapter 2: Materials and Methods……………………………….……………………….…….24 2.1 Cell culture and transfection...……………………….………………………………24 2.2 Plasmids and chemicals...………………………………….………………………...24 2.3 Immunoblotting (IB) and Immunoprecipitation (IP).…...…….……………………..25 2.4 Quantitation …………………………………………………….……………………25 2.5 Tead reporter assay ….…………...………..………………………………………...26 2.6 Immunofluorescence microscopy……...…………………………………………….26 2.7 Quantitative Real-Time PCR …...…...…………………………..…………………..27 Chapter 3: Results………………………………………………………….……………………32 3.1 LUMIER validation and characterization of βPix-Yap interaction……………….....32 3.1.1 βPix interacts with Taz and Yap….…………….………………………….32 3.1.2 Domain mapping of Pix and Yap.…………….…………..………………..34 3.1.2.1 KER of βPix is required for Yap interaction…...………………..34 3.1.2.2 Corresponding KER of αPix is required for Yap interaction…….38 3.2 Functional analysis of Pix in the Hippo pathway ....……………….………………..41 3.2.1 Analysis of βPix function via Tead reporter assay ……..……....…………41 3.2.2 αPix is not involved in the Hippo pathway in mouse mammary epithelial cells……………………………………………………………………………….43 3.3 Analysis of βPix GEF activity in Hippo pathway regulation………..………………43 3.3.1 βPix functions independent of GEF activity on Cdc42/Rac1 ……..………43 v 3.4 βPix and core Hippo kinases………….………….......................................................50 3.4.1 βPix and Lats kinases…...………………………………………………….50 3.4.1.1 βPix functions upstream of Lats kinases ………..……………….50 3.4.1.2 βPix does not affect phosphorylation status of Lats kinases at Thr1079/1041…………………………………………………………….50 3.4.2 βPix and Mst kinases...…….………………..……………………………..54 3.4.2.1 βPix does not interact with Mst kinases………………………….54 3.4.2.2 Increased expression of Mst by overexpressed βPIX……………57 3.4.2.3 Mst kinases bypass the canonical Hippo pathway……………….57 3.5 βPix as a re-coupler of the Hippo signal in metastatic cancer cell…………...……...62 Chapter 4: Discussion and the future direction…………….……………………..……………69 References……………………………………………………………………….………………76 vi List of Tables Table 1: List of siRNAs………………………………………………………………………….28 Table 2: Sequence of qPCR Primers (mouse)……..……………………………………………31 vii List of Figures Figure 1.1: The core Hippo pathway……………………………………………………………...2 Figure 1.2: Domain organization of core components of the Hippo pathway…………………….4 Figure 1.3: Domain organization of the homologous βPix and αPix………………………….…20 Figure 3.1: βPix interacts with Taz/Yap ………………………………………………………...33 Figure 3.2: A schematic representation of the wild-type and deletion cDNA constructs of βPIX and αPIX………………………………………………………………………………………...35 Figure 3.3: The KER of βPix is required for interaction with Yap………………………………36 Figure 3.4: The KER of αPix is required for interaction with Yap……………………………....37 Figure 3.5: The LZ domain is required for βPix dimerization…………………………………...39 Figure 3.6: The sequence alignment of human β/αPIX, showing amino acid sequence of a possible region of interaction with Yap………………………………………………………...40 Figure 3.7: βPix knockdown promotes accumulation of Yap/Taz in the nucleus……………….42 Figure 3.8: βPix GEF activity is dispensable for regulation of Yap/Taz ………..……………....45 Figure 3.9: βPix regulates Yap/Taz localization in response to cell density in a GEF-independent manner …………………………………………………………………………………………46 Figure 3.10: βPix regulates Yap/Taz localization in response to actin cytoskeleton rearrangement in a GEF-independent manner ………………………………………………………………….48 Figure 3.11: βPix functions upstream of Lats kinases…………………………………...………51 Figure 3.12: Phosphorylated Lats1/2 kinases at Thr1079/1041 localize to cell periphery………52 Figure 3.13: Knockdown of βPix does not affect the phosphorylation status at Thr1079/1041 on Lats1/2 kinases…………………………………………………………………………………...53 viii Figure 3.14: Overexpression of βPIX does not affect the phosphorylation status at Thr1079/1041 on Lats1/2 kinases………………………………………………………………………………..55 Figure 3.15: βPix does not interact with Mst kinases …………………………………………...56 Figure 3.16: Increased expression of Mst kinases by βPix is not physiologically relevant .….....58 Figure 3.17: Mst kinases bypass the canonical Hippo pathway in NMuMG cells ………….......59 Figure 3.18: Mst kinases bypass the canonical Hippo pathway in EpH4 cells.…………….........63 Figure 3.19: LATS1/2 kinases are required for βPIX-mediated YAP/TAZ inactivation in MDA- MB-231 cells……………………………………………………………………………………..66 Figure 4.1: Model of the regulatory mechanism of βPix in the Hippo pathway………………...73 ix 1 Chapter 1 Introduction In developmental biology, the fundamental biological processes of cell proliferation, differentiation and death have been extensively explored. Proliferation ensures growth during development and proper differentiation of multiple cell types assures their functionality, while appropriate apoptosis functions to replace defective cells. Coordination of these vital processes is critical for a wide range of physiological phenomena such as the exquisite control of organ size. The mechanisms underlying the regulation of organ size had remained under a veil until the emergence of the Hippo signalling pathway approximately two decades ago. Not only has the Hippo pathway been recognized as a master regulator of organ size, this complex signalling network plays critical roles in diverse cellular processes such as tissue homeostasis and regeneration, cell fate and stem cell self-renewal (Tapon et al. 2002, Harvey et al. 2003, Jia et al. 2003, Udan et al. 2003, Wu et al. 2003; Zhao et al. 2008). Dysfunction of the Hippo pathway is also implicated in pathological conditions including tumourigenesis and organ degeneration (O’Neill et al. 2004; Jonasson et al. 2007; Cordenonsi et al. 2011; Nishio et al.
Recommended publications
  • Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells
    Leukemia (2010) 24, 756–764 & 2010 Macmillan Publishers Limited All rights reserved 0887-6924/10 $32.00 www.nature.com/leu ORIGINAL ARTICLE Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells A Pellagatti1, M Cazzola2, A Giagounidis3, J Perry1, L Malcovati2, MG Della Porta2,MJa¨dersten4, S Killick5, A Verma6, CJ Norbury7, E Hellstro¨m-Lindberg4, JS Wainscoat1 and J Boultwood1 1LRF Molecular Haematology Unit, NDCLS, John Radcliffe Hospital, Oxford, UK; 2Department of Hematology Oncology, University of Pavia Medical School, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; 3Medizinische Klinik II, St Johannes Hospital, Duisburg, Germany; 4Division of Hematology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden; 5Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK; 6Albert Einstein College of Medicine, Bronx, NY, USA and 7Sir William Dunn School of Pathology, University of Oxford, Oxford, UK To gain insight into the molecular pathogenesis of the the World Health Organization.6,7 Patients with refractory myelodysplastic syndromes (MDS), we performed global gene anemia (RA) with or without ringed sideroblasts, according to expression profiling and pathway analysis on the hemato- poietic stem cells (HSC) of 183 MDS patients as compared with the the French–American–British classification, were subdivided HSC of 17 healthy controls. The most significantly deregulated based on the presence or absence of multilineage dysplasia. In pathways in MDS include interferon signaling, thrombopoietin addition, patients with RA with excess blasts (RAEB) were signaling and the Wnt pathways. Among the most signifi- subdivided into two categories, RAEB1 and RAEB2, based on the cantly deregulated gene pathways in early MDS are immuno- percentage of bone marrow blasts.
    [Show full text]
  • Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model
    Downloaded from http://www.jimmunol.org/ by guest on September 25, 2021 T + is online at: average * The Journal of Immunology , 34 of which you can access for free at: 2016; 197:1477-1488; Prepublished online 1 July from submission to initial decision 4 weeks from acceptance to publication 2016; doi: 10.4049/jimmunol.1600589 http://www.jimmunol.org/content/197/4/1477 Molecular Profile of Tumor-Specific CD8 Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A. Waugh, Sonia M. Leach, Brandon L. Moore, Tullia C. Bruno, Jonathan D. Buhrman and Jill E. Slansky J Immunol cites 95 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html http://www.jimmunol.org/content/suppl/2016/07/01/jimmunol.160058 9.DCSupplemental This article http://www.jimmunol.org/content/197/4/1477.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of September 25, 2021. The Journal of Immunology Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A.
    [Show full text]
  • Spatiotemporal Profiling of Cytosolic Signaling Complexes in Living Cells by Selective Proximity Proteomics
    ARTICLE https://doi.org/10.1038/s41467-020-20367-x OPEN Spatiotemporal profiling of cytosolic signaling complexes in living cells by selective proximity proteomics Mi Ke1,6, Xiao Yuan1,6,AnHe1, Peiyuan Yu 1, Wendong Chen1, Yu Shi2, Tony Hunter 2, Peng Zou 3 & ✉ Ruijun Tian 1,4,5 1234567890():,; Signaling complexes are often organized in a spatiotemporal manner and on a minute timescale. Proximity labeling based on engineered ascorbate peroxidase APEX2 pioneered in situ capture of spatiotemporal membrane protein complexes in living cells, but its appli- cation to cytosolic proteins remains limited due to the high labeling background. Here, we develop proximity labeling probes with increased labeling selectivity. These probes, in combination with label-free quantitative proteomics, allow exploring cytosolic protein assemblies such as phosphotyrosine-mediated protein complexes formed in response to minute-scale EGF stimulation. As proof-of-concept, we systematically profile the spatio- temporal interactome of the EGFR signaling component STS1. For STS1 core complexes, our proximity proteomics approach shows comparable performance to affinity purification-mass spectrometry-based temporal interactome profiling, while also capturing additional— especially endosomally-located—protein complexes. In summary, we provide a generic approach for exploring the interactome of mobile cytosolic proteins in living cells at a tem- poral resolution of minutes. 1 Department of Chemistry, School of Science, Southern University of Science and Technology, Shenzhen, China. 2 Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, CA, USA. 3 College of Chemistry and Molecular Engineering, Peking University, Beijing, China. 4 Guangdong Provincial Key Laboratory of Cell Microenvironment and Disease Research, Southern University of Science and Technology, Shenzhen, China.
    [Show full text]
  • Gene Section Review
    Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL AT INIST-CNRS Gene Section Review PARVB (parvin, beta) Cameron N Johnstone Cancer Metastasis Laboratory, Research Division, Peter MacCallum Cancer Centre, 2 St Andrew's Place, East Melbourne, 3002, Victoria, Australia (CNJ) Published in Atlas Database: April 2010 Online updated version : http://AtlasGeneticsOncology.org/Genes/PARVBID46486ch22q13.html DOI: 10.4267/2042/44936 This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. © 2011 Atlas of Genetics and Cytogenetics in Oncology and Haematology Identity DNA/RNA Other names: CGI-56, affixin, beta-parvin Note HGNC (Hugo): PARVB Genethon marker D22S1171 is located at the 5' end of Location: 22q13.31 the gene (Mongroo et al., 2004). Genethon marker Local order: PARVB is located telomeric to the D22S1171 is located between exon 2 and exon 1A of SAMM50 gene and centromeric to the PARVG gene the PARVB gene. at 22q13.31. The PARVA gene is located at 11p15.3. Figure A. Generation of transcript diversity by alternative promoter usage. Horizontal lines above the gene structure indicate human genomic DNA BAC clones. The NCBI accession numbers of the clones, and clone names (in brackets) are shown. Figure adapted from Mongroo et al., 2004. Atlas Genet Cytogenet Oncol Haematol. 2011; 15(1) 34 PARVB (parvin, beta) Johnstone CN Figure B. Human polyA+ RNA Multiple Tissue Northern blot (Origene) probed with full-length PARVB1 cDNA probe radiolabeled to a specific activity of > 5 x 108 cpm / mg (Johnstone C.N., unpublished). The two PARVB mRNA transcripts are indicated.
    [Show full text]
  • Epigenetic Mechanisms Are Involved in the Oncogenic Properties of ZNF518B in Colorectal Cancer
    Epigenetic mechanisms are involved in the oncogenic properties of ZNF518B in colorectal cancer Francisco Gimeno-Valiente, Ángela L. Riffo-Campos, Luis Torres, Noelia Tarazona, Valentina Gambardella, Andrés Cervantes, Gerardo López-Rodas, Luis Franco and Josefa Castillo SUPPLEMENTARY METHODS 1. Selection of genomic sequences for ChIP analysis To select the sequences for ChIP analysis in the five putative target genes, namely, PADI3, ZDHHC2, RGS4, EFNA5 and KAT2B, the genomic region corresponding to the gene was downloaded from Ensembl. Then, zoom was applied to see in detail the promoter, enhancers and regulatory sequences. The details for HCT116 cells were then recovered and the target sequences for factor binding examined. Obviously, there are not data for ZNF518B, but special attention was paid to the target sequences of other zinc-finger containing factors. Finally, the regions that may putatively bind ZNF518B were selected and primers defining amplicons spanning such sequences were searched out. Supplementary Figure S3 gives the location of the amplicons used in each gene. 2. Obtaining the raw data and generating the BAM files for in silico analysis of the effects of EHMT2 and EZH2 silencing The data of siEZH2 (SRR6384524), siG9a (SRR6384526) and siNon-target (SRR6384521) in HCT116 cell line, were downloaded from SRA (Bioproject PRJNA422822, https://www.ncbi. nlm.nih.gov/bioproject/), using SRA-tolkit (https://ncbi.github.io/sra-tools/). All data correspond to RNAseq single end. doBasics = TRUE doAll = FALSE $ fastq-dump -I --split-files SRR6384524 Data quality was checked using the software fastqc (https://www.bioinformatics.babraham. ac.uk /projects/fastqc/). The first low quality removing nucleotides were removed using FASTX- Toolkit (http://hannonlab.cshl.edu/fastxtoolkit/).
    [Show full text]
  • Expression of Parvin-Β Is a Prognostic Factor for Patients with Urothelial Cell
    British Journal of Cancer (2010) 103, 852 – 860 & 2010 Cancer Research UK All rights reserved 0007 – 0920/10 www.bjcancer.com Expression of parvin-b is a prognostic factor for patients with urothelial cell carcinoma of the upper urinary tract 1,2 3 1 4,5 4 6 2,7 ,2,4, C-F Wu , K-F Ng , C-S Chen , P-L Chang , C-K Chuang , W-H Weng , S-K Liao and S-T Pang* 1Department of Surgery, Division of Urology, Chia-Yi Chang Gung Memorial Hospital, Chia-Yi, Taiwan; 2Graduate Institute of Clinical Medical Sciences, Chang Gung University, Kwei-shan, Taoyuan, Taiwan; 3Department of Pathology, Lin-Kou Chang Gung Memorial Hospital, Kwei-shan, Taoyuan, Taiwan; 4 5 Department of Surgery, Division of Urology, Lin-Kou Chang Gung Memorial Hospital, No. 5, Fushing Road, Kwei-Shan, Taoyuan, Taiwan; Chang Gung 6 Bioinformatics Center, Lin-Kou Chang Gung Memorial Hospital, Kwei-shan, Taoyuan, Taiwan; Department of Chemical Engineering and Biotechnology, 7 Graduate Institute of Biotechnology, National Taipei University of Technology, Taipei, Taiwan; Cancer Immunotherapy Program, Taipei Medical University Hospital, Taipei, Taiwan BACKGROUND: Parvin-b (ParvB), a potential tumour suppressor gene, is a focal adhesion protein. We evaluated the role of ParvB in the upper urinary tract urothelial cell carcinoma (UUT-UC). METHODS: ParvB mRNA and proteins levels in UUT-UC tissue were investigated by quantitative real-time polymerase chain reaction and western blot analysis, respectively. In addition, the expression of ParvB in tissues from patients with UUT-UC at different stages was evaluated by immunohistochemistry. Furthermore, biological functions of ParvB in urothelial cancer cells were investigated using a doxycycline-inducible overexpression system and siRNA.
    [Show full text]
  • Defining the Phospho-Adhesome Through The
    ARTICLE Received 29 Jul 2014 | Accepted 9 Jan 2015 | Published 13 Feb 2015 DOI: 10.1038/ncomms7265 OPEN Defining the phospho-adhesome through the phosphoproteomic analysis of integrin signalling Joseph Robertson1, Guillaume Jacquemet1,w, Adam Byron1,w, Matthew C. Jones1, Stacey Warwood2, Julian N. Selley2, David Knight2, Jonathan D. Humphries1 & Martin J. Humphries1 Cell–extracellular matrix (ECM) adhesion is a fundamental requirement for multicellular existence due to roles in positioning, proliferation and differentiation. Phosphorylation plays a major role in adhesion signalling; however, a full understanding of the phosphorylation events that occur at sites of adhesion is lacking. Here we report a proteomic and phosphoproteomic analysis of adhesion complexes isolated from cells spread on fibronectin. We identify 1,174 proteins, 499 of which are phosphorylated (1,109 phosphorylation sites), including both well-characterized and novel adhesion-regulated phosphorylation events. Immunoblotting suggests that two classes of phosphorylated residues are found at adhesion sites—those induced by adhesion and those constitutively phosphorylated but recruited in response to adhesion. Kinase prediction analysis identifies novel kinases with putative roles in adhesion signalling including CDK1, inhibition of which reduces adhesion complex formation. This phospho-adhesome data set constitutes a valuable resource to improve our understanding of the signalling mechanisms through which cell–ECM interactions control cell behaviour. 1 Wellcome Trust Centre for Cell-Matrix Research, Faculty of Life Sciences, University of Manchester, Manchester M13 9PT, UK. 2 Biological Mass Spectrometry Core Facility, Faculty of Life Sciences, University of Manchester, Manchester M13 9PT, UK. w Present addresses: Turku Centre for Biotechnology, University of Turku, 20520 Turku, Finland (G.J.); Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh EH4 2XR, UK (A.B.).
    [Show full text]
  • Targeted Next-Generation Sequencing and Fine Linkage Disequilibrium Mapping Reveals Association of PNPLA3 and PARVB with The
    Journal of Human Genetics (2014) 59, 241–246 & 2014 The Japan Society of Human Genetics All rights reserved 1434-5161/14 www.nature.com/jhg ORIGINAL ARTICLE Targeted next-generation sequencing and fine linkage disequilibrium mapping reveals association of PNPLA3 and PARVB with the severity of nonalcoholic fatty liver disease Takuya Kitamoto1, Aya Kitamoto1, Masato Yoneda2, Hideyuki Hyogo3, Hidenori Ochi3, Seiho Mizusawa1, Takato Ueno4, Kazuwa Nakao5, Akihiro Sekine1, Kazuaki Chayama3, Atsushi Nakajima2 and Kikuko Hotta1 The genomic regions containing PNPLA3, SAMM50 and PARVB are susceptibility loci for the development and progression of nonalcoholic fatty liver disease (NAFLD). In order to search for all common variations in this region, we amplified the genomic DNA of 28 NAFLD patients by long-range PCR, covering the entire susceptibility region and sequenced the DNA using indexed multiplex next-generation sequencing. We found 329 variations, including four novel variations. Fine mapping of variations including insertion/deletions was performed for 540 NAFLD patients (488 with nonalcoholic steatohepatitis (NASH) and 52 with simple steatosis) and 1012 control subjects. HaploView analysis showed that linkage disequilibrium (LD) block 1 and 2 occurred in PNPLA3, block 3 in SAMM50 and block 4 in PARVB. Variations in LD blocks 1–4 were significantly associated with NAFLD as compared with control subjects (Po1 Â 10 À8). Variations in LD block 2 were significantly associated with the NAFLD activity score (NAS), aspartate aminotransferase and alanine aminotransferase. Variations in LD block 1 were significantly associated with the fibrosis stage. The strongest associations were observed for variations in LD block 4, with NASH as compared with simple steatosis (P ¼ 7.1 Â 10 À6) and NAS (P ¼ 3.4 Â 10 À6).
    [Show full text]
  • 1 a Framework to Identify Modifier Genes in Patients With
    bioRxiv preprint doi: https://doi.org/10.1101/117978; this version posted March 18, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. A framework to identify modifier genes in patients with Phelan-McDermid syndrome Short running title: Mapping modifier genes in Phelan-McDermid Syndrome Anne-Claude Tabet1,2,3,4¶, Thomas Rolland2,3,4¶, Marie Ducloy2,3,4, Jonathan Lévy1, Julien Buratti2,3,4, Alexandre Mathieu2,3,4, Damien Haye1, Laurence Perrin1, Céline Dupont1, Sandrine Passemard1, Yline Capri1, Alain Verloes1, Séverine Drunat1, Boris Keren5, Cyril Mignot6, Isabelle Marey7, Aurélia Jacquette7, Sandra Whalen7, Eva Pipiras8, Brigitte Benzacken8, Sandra Chantot-Bastaraud9, Alexandra Afenjar10, Delphine Héron10, Cédric Le Caignec11, Claire Beneteau11, Olivier Pichon11, Bertrand Isidor11, Albert David11, Jean-Michel Dupont12, Stephan Kemeny13, Laetitia Gouas13, Philippe Vago13, Anne-Laure Mosca-Boidron14, Laurence Faivre15, Chantal Missirian16, Nicole Philip16, Damien Sanlaville17, Patrick Edery18, Véronique Satre19, Charles Coutton19, Françoise Devillard19, Klaus Dieterich20, Marie-Laure Vuillaume21, Caroline Rooryck21, Didier Lacombe21, Lucile Pinson22, Vincent Gatinois22, Jacques Puechberty22, Jean Chiesa23, James Lespinasse24, Christèle Dubourg25, Chloé Quelin25, Mélanie Fradin25, Hubert Journel26, Annick Toutain27, Dominique Martin28, Abdelamdjid Benmansour1,
    [Show full text]
  • Identification of Differentially Methylated Region (DMR) Networks Associated with Progression of Nonalcoholic Fatty Liver Disease
    www.nature.com/scientificreports OPEN Identifcation of diferentially methylated region (DMR) networks associated with progression of Received: 16 March 2018 Accepted: 29 August 2018 nonalcoholic fatty liver disease Published: xx xx xxxx Kikuko Hotta 1, Aya Kitamoto2, Takuya Kitamoto2, Yuji Ogawa3, Yasushi Honda3, Takaomi Kessoku3, Masato Yoneda3, Kento Imajo3, Wataru Tomeno3,4, Satoru Saito3 & Atsushi Nakajima3 The progression of nonalcoholic fatty liver disease (NAFLD) is afected by epigenetics. We performed diferentially methylated region (DMR) and co-methylation analyses to identify DMR networks associated with the progression of NAFLD. DMRs displaying diferences in multiple consecutive diferentially methylated CpGs between mild and advanced NAFLD were extracted. The average values of topological overlap measures for the CpG matrix combining two diferent DMRs were calculated and two DMR networks that strongly correlated with the stages of fbrosis were identifed. The annotated genes of one network included genes involved in transcriptional regulation, cytoskeleton organization, and cellular proliferation. The annotated genes of the second network were primarily associated with metabolic pathways. The CpG methylation levels in these networks were strongly afected by age and fasting plasma glucose levels, which may be important co-regulatory factors. The methylation status of fve DMRs in the second network was reversible following weight loss. Our results suggest that CpG methylation in DMR networks is regulated concomitantly via aging
    [Show full text]
  • Mutations in EBF3 Disturb Transcriptional Profiles and Underlie a Novel Syndrome of Intellectual Disability, Ataxia and Facial D
    bioRxiv preprint doi: https://doi.org/10.1101/067454; this version posted August 3, 2016. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Mutations in EBF3 disturb transcriptional profiles and underlie a novel syndrome of 2 intellectual disability, ataxia and facial dysmorphism 3 4 Frederike Leonie Harms1,23, Katta Mohan Girisha2,23, Andrew A. Hardigan3,4,23, Fanny 5 Kortüm1, Anju Shukla2, Malik Alawi5,6,7, Ashwin Dalal8, Lauren Brady9, Mark 6 Tarnopolsky9, Lynne M. Bird10,11, Sophia Ceulemans11, Martina Bebin12, Kevin M. 7 Bowling3, Susan M. Hiatt3, Edward J. Lose13, Michelle Primiano14, Wendy K. Chung14, 8 Jane Juusola15, Zeynep C. Akdemir16, Matthew Bainbridge17, Wu-Lin Charng16, Margaret 9 Drummond-Borg18, Mohammad K. Eldomery16, Ayman W. El-Hattab19, Mohammed A. 10 M. Saleh20, Stéphane Bézieau21, Benjamin Cogné21, Bertrand Isidor21,22, Sébastien Küry21, 11 James R. Lupski16, Richard M. Myers3, Gregory M. Cooper3, Kerstin Kutsche1 12 13 1Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, 14 Germany 15 2Department of Medical Genetics, Kasturba Medical College, Manipal University, Manipal, 16 India 17 3HudsonAlpha Institute for Biotechnology, Huntsville, AL USA 18 4Department of Genetics, University of Alabama at Birmingham, AL USA 19 5University Medical Center Hamburg-Eppendorf, Bioinformatics Service Facility, Hamburg, 20 Germany 21 6Center for Bioinformatics, University of Hamburg, Hamburg,
    [Show full text]
  • Analysis of Genotype, Phenotype, and Age Progression in Phelan-Mcdermid Syndrome Sara Sarasua Clemson University, [email protected]
    Clemson University TigerPrints All Dissertations Dissertations 12-2012 Analysis of Genotype, Phenotype, and Age Progression in Phelan-McDermid Syndrome Sara Sarasua Clemson University, [email protected] Follow this and additional works at: https://tigerprints.clemson.edu/all_dissertations Part of the Genetics and Genomics Commons Recommended Citation Sarasua, Sara, "Analysis of Genotype, Phenotype, and Age Progression in Phelan-McDermid Syndrome" (2012). All Dissertations. 1032. https://tigerprints.clemson.edu/all_dissertations/1032 This Dissertation is brought to you for free and open access by the Dissertations at TigerPrints. It has been accepted for inclusion in All Dissertations by an authorized administrator of TigerPrints. For more information, please contact [email protected]. ANALYSIS OF GENOTYPE, PHENOTYPE, AND AGE PROGRESSION OF PHELAN-MCDERMID SYNDROME A Dissertation Presented to the Graduate School of Clemson University In Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy Genetics by Sara Moir Sarasua December 2012 Accepted by: Dr. Amy Lawton-Rauh, Committee Chair Dr. Chin-Fu Chen Dr. Leigh Anne Clark Dr. Barbara R. DuPont Dr. Alex Feltus ABSTRACT Phelan-McDermid syndrome is a developmental disability syndrome associated with deletions of the terminal end of one copy of chromosome 22q13. The observed chromosomal aberrations include simple terminal deletions, interstitial deletions, deletions and duplications, and duplications without deletions. All patients have some degree of developmental disability and many also have hypotonia, autism, minor dysmorphic features, and seizures. I performed an epidemiological and cytogenetic investigation to better understand the etiology of Phelan- McDermid syndrome and to provide information to patients and their families, clinicians, and researchers investigating developmental disabilities.
    [Show full text]